Protagenic Therapeutics, Inc.new (PTIX) Sale and Maturity of Investments (2009 - 2024)
Protagenic Therapeutics, Inc.new's Sale and Maturity of Investments - Total came in at $3.1 million for FY2024 (year ended Dec 31, 2024), down 59.7% from $7.69 million in FY2023.
Protagenic Therapeutics, Inc.new (PTIX) Sale and Maturity of Investments (2009 - 2024) Analysis & Trends
Going back to FY2009, Protagenic Therapeutics, Inc.new's Sale and Maturity of Investments - Total data covers 8 fiscal years.
- Sale and Maturity of Investments - Total carries a five-year compound annual growth rate of 65.5% (FY2019 to FY2024).
- The five-year range for annual Sale and Maturity of Investments - Total is $485,946 (FY2021) to $7.69 million (FY2023).
- Per Business Quant, earlier fiscal years put Sale and Maturity of Investments - Total at $7.69 million in FY2023 (+370.9%), $1.63 million in FY2022 (+236.0%) and $485,946 in FY2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 5.12 Mn |
| Sep 30, 2023 | 659,508.00 |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 294,669.00 |
| Dec 31, 2022 | 94,334.00 |
| Sep 30, 2022 | 460,888.00 |
| Jun 30, 2022 | 706,916.00 |
| Mar 31, 2022 | 370,763.00 |
| Mar 31, 2019 | 250,000.00 |
| Dec 31, 2018 | 620,000.00 |
| Sep 30, 2018 | 950,000.00 |
| Jun 30, 2018 | 585,000.00 |
| Mar 31, 2018 | 1.64 Mn |
| Dec 31, 2017 | 450,000.00 |
| Sep 30, 2017 | 975,000.00 |
| Jun 30, 2009 | 242,000.00 |
| Mar 31, 2009 | 4.00 Mn |
Protagenic Therapeutics, Inc.new Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();